Evidence map›Paper›PMID 41031098›Full record

ArticleERJ open research2025

Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosis.

Olivia C Leavy, Anne F Goemans, Tamara Hernandez-Beeftink, Amy D Stockwell, Richard J Allen, Beatriz Guillen-Guio, Ayodeji Adegunsoye, Helen L Booth, William A Fahy, Tasha E Fingerlin and 31 more

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Olivia C LeavyDepartment of Population Health Sciences, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-1503-5535
Anne F GoemansDepartment of Population Health Sciences, University of Leicester, Leicester, UK.ORCID https://orcid.org/0009-0004-4014-4735
Tamara Hernandez-BeeftinkDepartment of Population Health Sciences, University of Leicester, Leicester, UK.
Amy D StockwellGenentech, South San Francisco, CA, USA.
Richard J AllenDepartment of Population Health Sciences, University of Leicester, Leicester, UK.
Beatriz Guillen-GuioDepartment of Population Health Sciences, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-3703-1738
Ayodeji AdegunsoyeUniversity of Chicago, Chicago, IL, USA.
Helen L BoothUniversity College London Hospitals NHS Foundation Trust, London, UK.
William A FahyGSK, London, UK.
Tasha E FingerlinNational Jewish Health, Denver, CO, USA.
Harvinder S VirkNational Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.
Ian P HallUniversity of Nottingham, Nottingham, UK.
Simon P HartUniversity of Hull, Hull, UK.ORCID https://orcid.org/0000-0003-4606-9559
Mike R HillUniversity of Oxford, Oxford, UK.
Nik HiraniUniversity of Edinburgh, Edinburgh, UK.
Naftali KaminskiYale School of Medicine, Yale University, New Haven, CT, USA.ORCID https://orcid.org/0000-0001-5917-4601
Shwu-Fan MaUniversity of Virginia, Charlottesville, VA, USA.ORCID https://orcid.org/0000-0002-3058-9480
Robin J McAnultyUniversity College London, London, UK.
X Rebecca ShengGenentech, South San Francisco, CA, USA.
Ann B MillarUniversity of Bristol, Bristol, UK.
Maria Molina-MolinaServei de Pneumologia, Laboratori de Pneumologia Experimental, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
Vidya NavaratnamDepartment of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia.ORCID https://orcid.org/0000-0002-2914-8012
Margaret NeighborsGenentech, South San Francisco, CA, USA.
Helen ParfreyRoyal Papworth Hospital NHS Foundation Trust, Cambridge, UK.ORCID https://orcid.org/0000-0002-4515-5634
Gauri SainiUniversity of Nottingham, Nottingham, UK.
Ian SayersCentre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK.ORCID https://orcid.org/0000-0001-5601-5410
Mary E StrekUniversity of Chicago, Chicago, IL, USA.
Martin D TobinDepartment of Population Health Sciences, University of Leicester, Leicester, UK.
Moira K B WhyteUniversity of Edinburgh, Edinburgh, UK.
Yingze ZhangUniversity of Pittsburgh, Pittsburgh, PA, USA.
Toby M MaherNIHR Imperial Biomedical Research Centre, National Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-7192-9149
Philip L MolyneauxNIHR Imperial Biomedical Research Centre, National Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-1301-8800
Justin M OldhamUniversity of Michigan, Ann Arbor, MI, USA.
Brian L YaspanGenentech, South San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-3787-2510
Carlos FloresCentro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Fernando MartinezWeill Cornell Medicine, New York, NY, USA.
Carl J ReynoldsImperial College London, London, UK.ORCID https://orcid.org/0000-0002-7415-258X
David A SchwartzUniversity of Colorado Medicine, Denver, CO, USA.
Imre NothUniversity of Virginia, Charlottesville, VA, USA.
R Gisli JenkinsNIHR Imperial Biomedical Research Centre, National Heart and Lung Institute, Imperial College London, London, UK.
Louise V WainDepartment of Population Health Sciences, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0003-4951-1867

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition that is more prevalent in males than females. The reasons for this are not fully understood; differing environmental exposures due to historically sex-biased occupations and diagnostic bias are possible explanations. To date, over 20 independent genetic association signals have been reported for IPF susceptibility, but these have been discovered when combining males and females. The objectives of the present study were to assess whether there is a need to consider sex-specific effects when evaluating genetic risk in clinical prediction models for IPF and to test for sex-specific associations with IPF susceptibility. Methods: We performed a genome-wide single nucleotide polymorphism (SNP)-by-sex interaction study meta-analysis of IPF risk in six independent case-control studies comprising 4561 cases (1280 females, 3281 males) and 22 888 controls (8360 females, 14 528 males) of European genetic ancestry. We used polygenic risk scores (PRSs) comprising common (minor allele frequency >1%) autosomal variants to assess differences in genetic risk prediction between males and females. Results: The predictive accuracy of the PRSs were similar between males and females, regardless of whether using combined or sex-specific association results. Three new independent genetic association signals were identified (p<1×10 Conclusions: The predictive accuracy of common autosomal SNP-based PRSs did not vary significantly between males and females. We prioritised three genetic variants whose effect on IPF risk may be modified by sex. These findings would not account for the differences in prevalence between males and females. Future studies should ensure adequate representation of both sexes.

Identifiers

PMID41031098
PMCPMC12477485

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.